Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
Tarun Kaushik, Muhammad Magdi YaqoobBarts Health NHS Trust, William Harvey Research Unit, London, UKAbstract: Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for the ideal treatment of anemia in chronic kidney disease (CKD) patients. Reduced frequency of administration...
Main Authors: | Kaushik T, Yaqoob MM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-11-01
|
Series: | Biologics: Targets & Therapy |
Online Access: | http://www.dovepress.com/lessons-learned-from-peginesatide-in-the-treatment-of-anemia-associate-a14949 |
Similar Items
-
Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis
by: Mikhail A
Published: (2012-05-01) -
A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis.
by: Himanshu Naik, et al.
Published: (2013-01-01) -
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
by: Besarab Anatole, et al.
Published: (2012-08-01) -
A Population Pharmacokinetic (Pk)- Pharmacodynamic (Pd) Analysis Of Peginesatide India Lysis Patients With Chronic Kidney Disease
by: Himanshu Naik, et al.
Published: (2012-06-01) -
Estimation of peginesatide utilization requires patient-level data
by: Alex Yang, et al.
Published: (2012-06-01)